pyrimidine has been researched along with Autoimmune Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, M; Deshpande, I; Nayak, RR; Patterson, AD; Rimal, B; Scher, JU; Stapleton-Gray, K; Turnbaugh, PJ; Ubeda, C | 1 |
| Che, J; Chow, D; Gray, NS; He, Y; Iskandar, M; Karanewsky, DS; Liu, Y; Martin Seidel, H; Ren, P; Romeo, R; Sandberg, ML; Sim, T; Spalding, TA; Tian, SS; Wang, X; Zhang, G | 1 |
2 other study(ies) available for pyrimidine and Autoimmune Diseases
| Article | Year |
|---|---|
Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation.
Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Bacteria; Female; Gastrointestinal Microbiome; Gastrointestinal Tract; Humans; Metabolomics; Methotrexate; Mice; Mice, Inbred C57BL; Phylogeny; Purines; Pyrimidines; RNA, Ribosomal, 16S; Tetrahydrofolate Dehydrogenase; Transcriptome | 2021 |
Discovery of pyrimidine benzimidazoles as Lck inhibitors: part I.
Topics: Autoimmune Diseases; Benzimidazoles; Chemistry, Pharmaceutical; Drug Design; Humans; Inhibitory Concentration 50; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Models, Chemical; Molecular Conformation; Protein-Tyrosine Kinases; Pyrimidines; Solubility; src-Family Kinases; Structure-Activity Relationship | 2008 |